secwatch.observer — SEC 8-K summary
======================================

Issuer:     InfuSystem Holdings, Inc (INFU)
CIK:        0001337013
Form:       8-K
Filed at:   2023-08-03T23:59:59+00:00
Accession:  0001628280-23-026963
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InfuSystem reports record Q2 revenue of $31.7M (+17% YoY), net income $0.4M, raises FY guidance
--------------------------------------------------------------------------------

- Net revenue record $31.7M (+17% YoY); Patient Services $19.3M (+12%), Device Solutions $12.4M (+27%).
- Net income $0.4M ($0.02 diluted EPS) vs net loss -$0.2M (-$0.01) in Q2 2022.
- Adjusted EBITDA $5.8M (18.2% margin), up 4% YoY and 36% sequentially.
- FY 2023 guidance raised: revenue growth above prior 8-10% range; Adj EBITDA margin 17-18%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1337013/000162828023026963/0001628280-23-026963-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1337013/000162828023026963/infu-20230803.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-026963

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer